1. Azadnajafabad S, Mohammadi E, Aminorroaya A, Fattahi N, Rezaei S, Haghshenas R, et al. Non-communicable diseases' risk factors in Iran; a review of the present status and action plans. Journal of Diabetes and Metabolic Disorders 2021;22:1-9 [
DOI:10.1007/s40200-020-00709-8]
2. Institute for Health Metrics and Evaluation (IHME). Global Health Data exchange (GHDx) 2019. Available on: http://ghdx.healthdata.org/gbd-results-tool [Accessed 21 Apr 2021]
3. Khosravi Shadmani F, Farzadfar F, Larijani B, Mirzaei M, Haghdoost AA. Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study. PloS one 2019;14:e0211622. [
DOI:10.1371/journal.pone.0211622]
4. Aminorroaya A, Fattahi N, Azadnajafabad S, Mohammadi E, Jamshidi K, Khalilabad MR, et al. Burden of non-communicable diseases in Iran: past, present, and future. Journal of Diabetes and Metabolic Disorders 2020;19:1-7 [
DOI:10.1007/s40200-020-00669-z]
5. Low W-Y, Lee Y-K, Samy AL. Non-communicable diseases in the Asia-Pacific region: Prevalence, risk factors and community-based prevention. International Journal of Occupational Medicine and Environmental Health 2015;28:20-6 [
DOI:10.2478/s13382-014-0326-0]
6. Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. Journal of Diabetes and Metabolic Disorders 2017;16:3 [
DOI:10.1186/s40200-017-0288-4]
7. Di Daniele N. The Role of Preventive Nutrition in Chronic Non-Communicable Diseases. Nutrients 2019;11:1074 [
DOI:10.3390/nu11051074]
8. Noce A, Marrone G, Di Daniele F, Ottaviani E, Wilson Jones G, Bernini R, et al. Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases. Nutrients 2019;11:1073 [
DOI:10.3390/nu11051073]
9. Fuller R. Probiotics in man and animals. Journal of Applied Microbiology 1989;66:365-78 [
DOI:10.1111/j.1365-2672.1989.tb05105.x]
10. Food and Agriculture Organization, World Health Organization. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada 2002:1:1-11
11. Sun‐Waterhouse D. The development of fruit‐based functional foods targeting the health and wellness market: a review. International Journal of Food Science and Technology 2011;46:899-920 [
DOI:10.1111/j.1365-2621.2010.02499.x]
12. Pandey KR, Naik SR, Vakil BV. Probiotics, prebiotics and synbiotics-a review. International Journal of Food Science & Technology 2015;52:7577-87 [
DOI:10.1007/s13197-015-1921-1]
13. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nature Reviews Genetics 2012;13:260-70 [
DOI:10.1038/nrg3182]
14. Dror T, Dickstein Y, Dubourg G, Paul M. Microbiota manipulation for weight change. Microbial Pathogenesis 2017;106:146-61 [
DOI:10.1016/j.micpath.2016.01.002]
15. Razmpoosh E, Javadi M, Ejtahed HS, Mirmiran P. Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review. Diabetes/Metabolism Research and Reviews 2016;32:143-68 [
DOI:10.1002/dmrr.2665]
16. Beserra BT, Fernandes R, do Rosario VA, Mocellin MC, Kuntz MG, Trindade EB. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clinical Nutrition 2015;34:845-58 [
DOI:10.1016/j.clnu.2014.10.004]
17. Hibberd AA, Lyra A, Ouwehand AC, Rolny P, Lindegren H, Cedgard L, et al. Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. BMJ Open Gastroenterology 2017;4:e000145 [
DOI:10.1136/bmjgast-2017-000145]
18. Bazhan M, Kalantari N, Keshavarz-Mohammadi N. Health-enhancing foods: barriers to consumers' choice in Iran. Health Promotion International. 2020; Avaialable on:
https://doi.org/10.1093/heapro/daaa088 [
DOI:10.1093/heapro/daaa088 [Accessed Apr 2021].]
19. Metchnikoff II. The prolongation of life: optimistic studies. 1st EditionOutlook Verlag GmbH: Germany, 2004
20. Sanders ME. Development of consumer probiotics for the US market. British Journal of Nutrition 1998;80:213-8 [
DOI:10.1017/S000711450000605X]
21. Nazir M, Arif S, Khan RS, Nazir W, Khalid N, Maqsood S. Opportunities and Challenges for Functional and Medicinal Beverages: Current and Future Trends. Trends in Food Science and Technology 2019;88:518-26 [
DOI:10.1016/j.tifs.2019.04.011]
22. Temesi A, Bacso A, Grunert KG, Lakner Z. Perceived correspondence of health effects as a new determinant influencing purchase intention for functional food. Nutrients 2019;11:740 [
DOI:10.3390/nu11040740]
23. Annunziata A, Vecchio R, Kraus A. Factors affecting parents' choices of functional foods targeted for children. International Journal of Consumer Studies 2016;40:527-35 [
DOI:10.1111/ijcs.12297]
24. Daliri EB-M, Lee BH. Current trends and future perspectives on functional foods and nutraceuticals. Beneficial microorganisms in food and nutraceuticals 2015;27:221-44 [
DOI:10.1007/978-3-319-23177-8_10]
25. Sorenson D, Bogue J. Consumer-oriented development of functional beverages. Functional and Speciality Beverage Technology 2009;3:421-50 [
DOI:10.1533/9781845695569.4.421]